(Q66079463)
Statements
A Randomized, 5-Period, 5-Treatment, Single-Dose, Open-Label, Single-Center, Crossover Study to Estimate the Effect of AZD5718 on the Pharmacokinetics of Rosuvastatin, and to Assess the Relative Bioavailability of AZD5718 Oral Suspension vs AZD5718 IR Tablet Formulation and the Food Effect of AZD5718. (English)
0 references
20 December 2016
0 references
1 March 2017
0 references
12
0 references
18 year
0 references
50 year
0 references